Roche to buy gene therapy specialist Spark in $4.3 billion deal

Roche Holding AG said on Monday it will buy Spark Therapeutics in a $4.3 billion deal, as the Swiss drugmaker builds its hemophilia portfolio and seeks to keep pace in gene therapy.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news